NARINFLA pushes Korea's skin diet approach with 3F ampoule

NARINFLA is taking its 3F Lifting Booster Ampoule global as more consumers look for simpler post-procedure routines and fewer, more targeted products. The Korean brand says the formula is built for home care after in-clinic treatments and has already seen repeated sell-outs in South Korea.

Why it matters: - Post-procedure skin care is moving toward simpler routines with fewer products and more concentrated formulas. - NARINFLA is positioning one ampoule as a replacement for several layers of daily care after aesthetic treatments. - The brand is expanding from Korea into international markets as demand rises for “skin diet” routines and slow-aging products.

What happened: - NARINFLA, a skincare brand developed by ROSEROAD Co., Ltd., introduced its 3F Lifting Booster Ampoule to international audiences on October 6, 2026. - The launch centers on care after ultrasound and laser-based lifting treatments. - NARINFLA says the product fits the post-clinic routine Korean clinics have long recommended: a gentle cleanser, one repair-focused product, a basic moisturizer and daily sun protection.

The details: - The 3F Lifting Booster Ampoule combines three growth factors: EGF, FGF and IGF. - The formula also includes a complex of 12 peptides. - NARINFLA says the ampoule reflects four years of research and development. - The product is formulated for elasticity care as part of a slow-aging routine. - In cosmetics, growth factors and peptides are often chosen for sensitive or recently treated skin. - NARINFLA received Dermatest’s top skin-compatibility rating, “Excellent,” from the independent German institute. - Dermatest ratings measure tolerability in testing, not treatment outcomes. - Since launch, NARINFLA says it has recorded 19 consecutive sell-outs of its production batches. - The brand says user reviews shared on social media drove much of that demand. - NARINFLA is now sold through selected dermatology clinics and professional skincare salons in Seoul, including Gangnam and Myeongdong. - The brand is based in Geumsan-gun, Chungcheongnam-do, South Korea. - NARINFLA develops growth factor and peptide skincare aligned with the slow-aging trend. - More information is available on the company’s website.

Between the lines: - The launch reflects a broader shift in skincare from multi-step routines to targeted products that are easier to maintain after in-clinic procedures. - The clinic and salon rollout suggests NARINFLA is leaning on professional channels to build trust, not just consumer advertising. - The Dermatest rating gives the brand a safety and compatibility signal that may matter most to sensitive-skin users.

What's next: - NARINFLA plans to keep expanding cooperation with dermatology clinics and professional skincare providers. - The company is also using international interest to move beyond its domestic market. - Consumers using the product are advised to patch-test first, use sunscreen daily and consult a dermatologist about specific skin concerns.

The bottom line: - NARINFLA is betting that post-procedure care will be won by one disciplined, skin-friendly ampoule rather than a long routine.